A trio of Galderma Group AG shareholders has sold their entire 14.3% stake in the Swiss skincare company for 6.3 billion dollars, marking the largest overnight share sale in Switzerland's history. The deal represents a significant exit for the investors who have backed the dermatology-focused firm through its growth phase.

The sale comes as Galderma continues to strengthen its position in the global skincare market, with the company known for its prescription and aesthetic dermatology products. The skincare industry has seen increased investor interest in recent years, driven by growing consumer demand for anti-aging and medical-grade skincare solutions.

This record-breaking transaction highlights the robust appetite for quality healthcare assets in European markets. The size and speed of the sale demonstrate strong institutional interest in Galderma's business model and future prospects, even as major shareholders choose to cash out their positions.